Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
J Mol Diagn
; 17(3): 251-64, 2015 May.
Article
in En
| MEDLINE
| ID: mdl-25801821
Full text:
1
Database:
MEDLINE
Main subject:
DNA Mutational Analysis
/
High-Throughput Nucleotide Sequencing
/
Neoplasms
Type of study:
Evaluation_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Year:
2015
Type:
Article